Estimation of the Safety and Efficiency Transfusion of HLA Matched CBU in Patients With CP

Patient selection criteria (indications for this type of treatment): * Patient age from 1 to 12 years; * Diagnosis: cerebral palsy, including postnatal damage after ischemic or hemorrhagic strokes, hypoxic or ischemic encephalopathy, periventricular leucomalacia; * The presence of I - V lesion levels on the GMFCS - ER (CanChild) scale; * The presence of a compatible allogeneic sample suitable for infusion; * Parental consent (official guardians) Patient exclusion criteria (contraindications for this type of treatment): * Patient age up to 1 year, older than 12 years; * The presence of the following diseases in history: heart failure in the stage of decompensation, anemia and other blood diseases; * Decompensation of chronic and endocrinological diseases; * Acute viral and bacterial infections during the acute clinical phase of the disease; * HIV infection, hepatitis of B and C types; * Oncological diseases, chemotherapy in the anamnesis; * Tuberculosis; * Confirmed genetic disorders; * A severe form of intellectual disability as a concomitant disease (diagnosis can be ignored, according to the decision of the Medical Committee of the Center); * Epileptic seizures with or without medication in the last 6 months before inclusion in the protocol.